HHT Foundation International, Inc.
Cockeysville, MD Doing business as Cure HHT
- UEI
- UNXYPCADCLR7
- CAGE
- 48JP7
- Primary NAICS
- 813212 Voluntary Health Organizations
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- Hollygate, 12 Galloway Ave Ste 2C, Cockeysville, MD 21030, USA
- Website
- curehht.org
- Founded
- 1991
- Employees
- 11-50
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Health Care Equipment & Services
- Health Care Providers & Services
- Health & Wellness
- SIC code
- 83 Social Services
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Pazopanib for HHT-related bleeding: extension trial | Defense Health Agency | $1,754,922 | |
| Hereditary hemorrhagic telangiectasia (HHT) program - hereditary hemorrhagic telangiectasia (HHT) is a rare genetic… | Office of Federal Assistance Management | $13,614,814 | |
| A phase II/III randomized, placebo controlled, double blind study to evaluate the effects of up to 24 weeks of low… | FDA Office of Acquisition and Grant Services | $1,356,330 | |
| Randomized trial for pazopanib in HHT-related bleeding | Defense Health Agency | $5,240,516 |
About HHT Foundation International, Inc.
HHT Foundation International, Inc., doing business as Cure HHT, is a non-profit organization and foundation registered in SAM.gov since 2005, focused on advancing research and support for Hereditary Hemorrhagic Telangiectasia (HHT), a rare genetic blood vessel disorder affecting approximately 1 in 5,000 individuals. Located in Monkton, Maryland, the organization serves as a patient advocacy group dedicated to improving understanding, treatment, and outcomes for individuals with HHT through scientific research, data collection, and medical coordination.
The organization has secured multiple significant federal grant awards from agencies including the Defense Health Agency, Maternal and Child Health Bureau, and the Office of Medical Products and Tobacco, primarily to conduct clinical research on HHT. These grants have focused on developing potential therapeutic interventions, most notably a series of clinical trials investigating pazopanib as a potential treatment for HHT-related bleeding and anemia. The grants include a $1,754,922 Department of the Army Medical Command award for an extension trial of pazopanib, a $446,404 grant to develop a national HHT data registry and care coordination program, and a grant from the FDA to conduct a phase II/III randomized, placebo-controlled study evaluating pazopanib's effects on epistaxis and anemia. The foundation's research aims to address the complex medical challenges of HHT, potentially leading to the first FDA-approved therapeutic for directly treating the disorder's symptoms, with a goal of improving patient quality of life and reducing mortality through advanced medical research and patient care coordination.
Quick answers
What is HHT Foundation International, Inc.'s UEI?
HHT Foundation International, Inc.'s Unique Entity ID (UEI) in SAM.gov is UNXYPCADCLR7.
What is HHT Foundation International, Inc.'s CAGE code?
HHT Foundation International, Inc.'s CAGE code is 48JP7.
What is HHT Foundation International, Inc.'s primary NAICS code?
HHT Foundation International, Inc.'s primary NAICS code is 813212 (Voluntary Health Organizations).
Where is HHT Foundation International, Inc. located?
HHT Foundation International, Inc.'s physical address in SAM.gov is Hollygate, 12 Galloway Ave Ste 2C, Cockeysville, MD 21030, USA.
Is HHT Foundation International, Inc. registered in SAM.gov?
Yes. HHT Foundation International, Inc.'s SAM.gov registration is active through July 8, 2027.
What is HHT Foundation International, Inc.'s most recent federal award?
HHT Foundation International, Inc.'s most recent federal grant award is Pazopanib for HHT-related bleeding: extension trial (HT94252510428), from Defense Health Agency, on July 1, 2025.
On GovTribe
See HHT Foundation International, Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors